Plasma homocysteine levels after hormone therapy with and without folic acid supplementation: A randomized study
Authors:
- Fabio GhezziFGFabio Ghezzi
- Marco ButtarelliMBMarco Buttarelli
- Antonella CromiACAntonella Cromi
- Luigi RaioLRLuigi Raio
- Marcelle CedarsMCMarcelle Cedars
- Pierfrancesco BolisPBPierfrancesco Bolis
- 1 September 2004
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 82 (3) , 746-748
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levelsMenopause, 2003
- Hyperhomocysteinaemia and cardiovascular risk in female ovariectomized rats: role of folic acid and hormone replacement therapyJournal of Pharmacy and Pharmacology, 2002
- Failure of the combination of sequential oral and transdermal estradiol plus norethisterone acetate to affect plasma homocysteine levelsFertility and Sterility, 2000
- Low-dose folic acid supplementation reduces plasma levels of the cardiovascular risk factor homocysteine in postmenopausal womenAmerican Journal of Obstetrics and Gynecology, 2000
- Hormone Replacement Therapy and Plasma Homocysteine LevelsObstetrics & Gynecology, 1999
- Postmenopausal Oral 17β-Estradiol Continuously Combined with Dydrogesterone Reduces Fasting Serum Homocysteine LevelsFertility and Sterility, 1998
- A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular DiseaseJAMA, 1995